Hasanein Parisa, Sharifi Maryam
a Department of Biology , School of Basic Sciences, Bu-Ali Sina University , Hamedan , Iran.
Pharm Biol. 2017 Dec;55(1):1809-1816. doi: 10.1080/13880209.2017.1331248.
Drug-induced liver injury is a significant worldwide clinical problem. Rosmarinic acid (RA), a natural phenol, has antioxidant effects.
The effects of RA against acetaminophen (N-acetyl-p-amino-phenol (APAP))-induced oxidative damage and hepatotoxicity in rats were investigated.
Male Wistar rats were pretreated with RA (10, 50 and 100 mg/kg, i.g.) for one week. On day 7, rats received APAP (500 mg/kg, i.p.). Then aspartate aminotransferase (AST), alanine aminotransferase (ALT), albumin, total protein, malondialdehyde (MDA), glutathione (GSH), total antioxidant capacity (TAC), glutathione S-transferase (GST), cytochrome CYP450 and histopathological changes were determined.
APAP-induced oxidative stress in liver by a significant increase in the level of MDA (7.6 ± 0.21 nmol/mg) as well as a decrease in the contents of TAC (1.75 ± 0.14 μmol/g), GSH (1.9 ± 0.22 μmol/g) and GST) 3.2 ± 0.28 U/mg). RA treatment decreased MDA (4.32 ± 0.35 nmol/mg) but increased the contents of TAC (3.51 ± 0.34 μmol/g), GSH (3.42 ± 0.16 μmol/g) and GST (5.71 ± 0.71 μmol/g) in APAP group. RA 100 mg/kg decreased ALT (91.5 ± 1.5 U/L), AST (169 ± 8.8 U/L) and CYP450 (3 ± 0.2 nmol/min/mg) in APAP group. Histologically RA attenuated hepatic damage by decreasing necrosis, inflammation, and haemorrhage in liver sections of APAP group.
This is the first report that oral administration of RA dose-dependently elicited significant hepatoprotective effects in rats through inhibition of hepatic CYP2E1 activity and lipid peroxidation. RA-protected hepatic GSH and GST reserves and total tissue antioxidant capacity.
药物性肝损伤是一个全球性的重大临床问题。迷迭香酸(RA)是一种天然酚类物质,具有抗氧化作用。
研究RA对大鼠对乙酰氨基酚(N - 乙酰 - 对氨基苯酚(APAP))诱导的氧化损伤和肝毒性的影响。
雄性Wistar大鼠用RA(10、50和100mg/kg,灌胃)预处理一周。在第7天,大鼠接受APAP(500mg/kg,腹腔注射)。然后测定天冬氨酸转氨酶(AST)、丙氨酸转氨酶(ALT)、白蛋白、总蛋白、丙二醛(MDA)、谷胱甘肽(GSH)、总抗氧化能力(TAC)、谷胱甘肽S - 转移酶(GST)、细胞色素CYP450以及组织病理学变化。
APAP通过显著提高MDA水平(7.6±0.21nmol/mg)以及降低TAC(1.75±0.14μmol/g)、GSH(1.9±0.22μmol/g)和GST(3.2±0.28U/mg)含量诱导肝脏氧化应激。RA处理降低了APAP组的MDA(4.32±0.35nmol/mg),但提高了TAC(3.51±0.34μmol/g)、GSH(3.42±0.16μmol/g)和GST(5.71±0.71U/mg)含量。RA 100mg/kg降低了APAP组的ALT(91.5±1.5U/L)、AST(169±8.8U/L)和CYP450(3±0.2nmol/min/mg)。组织学上,RA通过减少APAP组肝切片中的坏死、炎症和出血减轻了肝损伤。
这是首次报道口服RA通过抑制肝脏CYP2E1活性和脂质过氧化在大鼠中剂量依赖性地产生显著的肝保护作用。RA保护了肝脏GSH和GST储备以及组织总抗氧化能力。